Search results
Showing results for
Understanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient’s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.
Shuangye Yan
Shuangye Yan - Postdoctoral Researcher in Immune Oncology (Antibody Therapy)
Alex Gordon-Weeks
MBChB, BSc, DPhil, FRCS Alex Gordon-Weeks - Consultant Liver and Pancreas Surgeon
Yoshiaki Nakamura
Yoshiaki Nakamura - Royal Society Wolfson Visiting Fellow
Keaton Jones
BMBS BMedSci MSc PGDip DPhil FRCS Keaton Jones - Senior Clinical Researcher

